小鼠与人胃肿瘤整合分析鉴定胃癌发生中保守的微小RNA网络
研究对无胃肿瘤证据患者的正常胃组织(n=64)和TFF1基因敲除小鼠(n=22)进行下一代微小RNA测序,并在3个独立患者队列(共332例)及小鼠中验证。发现6个微小RNA在肿瘤中显著失调,其中MIR143-3p在肿瘤及癌旁正常组织、小鼠低级别异型增生中降低,其过表达可抑制胃癌细胞增殖并恢复顺铂敏感性,BRD2为其直接靶点且高表达与患者生存期缩短相关。
要点
- MIR135B-5p、MIR196B-5p、MIR92A-5p在胃肿瘤组织中升高,MIR143-3p、MIR204-5p、MIR133-3p降低。
- MIR143-3p在胃癌组织及癌旁正常组织中均降低,在小鼠低级别异型增生中亦降低。
- MIR143-3p过表达抑制胃癌细胞增殖、恢复顺铂敏感性,BRD2为其直接靶点,BRD2升高与生存期缩短相关。
核心结论
- 在小鼠和人类胃肿瘤的微小RNA谱分析中,鉴定出一个与胃肿瘤发生早期阶段相关的保守特征。
- 恢复MIR143-3p或抑制BRD2的策略可能被开发用于胃癌治疗。
研究设计与样本
- 对无胃肿瘤证据患者的正常胃组织(n=64)和TFF1基因敲除小鼠(n=22)进行下一代微小RNA测序分析。
- 用270份正常胃组织(包括61份无肿瘤病变患者样本)和来自3个独立患者队列及小鼠的234份胃肿瘤组织验证发现。
- 使用细胞系(MKN28、MKN45、STKM2和AGS细胞)、胃类器官和异种移植瘤小鼠进行分子和功能实验。
主要发现
- 在小鼠和人胃肿瘤组织与非肿瘤组织比较中,鉴定出117个显著失调的微小RNA。
- 通过定量实时聚合酶链反应在小鼠(n=39)和3个独立患者队列(共332例患者)的肿瘤胃组织中验证了6个微小RNA的水平变化。
- MIR135B-5p、MIR196B-5p和MIR92A-5p在肿瘤组织中升高,MIR143-3p、MIR204-5p和MIR133-3p在肿瘤组织中降低。
- MIR143-3p水平不仅在胃癌组织中降低,在人类癌旁正常组织和小鼠低级别异型增生中也降低。
- 胃癌细胞系中MIR143-3p转基因表达降低其增殖并恢复其对顺铂的敏感性;稳定表达MIR143-3p的AGS细胞在小鼠中作为异种移植瘤生长慢于对照AGS细胞,且表达MIR143-3p的AGS细胞肿瘤生长对顺铂敏感而对照细胞不敏感。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: microRNAs (miRNAs) are small noncoding RNAs that bind to the 3' untranslated regions of mRNAs to promote their degradation or block their translation. Mice with disruption of the trefoil factor 1 gene (Tff1) develop gastric neoplasms. We studied these mice to identify conserved miRNA networks involved in gastric carcinogenesis. METHODS: We performed next-generation miRNA sequencing analysis of normal gastric tissues (based on histology) from patients without evidence of gastric neoplasm (n = 64) and from TFF1-knockout mice (n = 22). We validated our findings using 270 normal gastric tissues (including 61 samples from patients without evidence of neoplastic lesions) and 234 gastric tumor tissues from 3 separate cohorts of patients and from mice. We performed molecular and functional assays using cell lines (MKN28, MKN45, STKM2, and AGS cells), gastric organoids, and mice with xenograft tumors. RESULTS: We identified 117 miRNAs that were significantly deregulated in mouse and human gastric tumor tissues compared with nontumor tissues. We validated changes in levels of 6 miRNAs by quantitative real-time polymerase chain reaction analyses of neoplastic gastric tissues from mice (n = 39) and 3 independent patient cohorts (n = 332 patients total). We found levels of MIR135B-5p, MIR196B-5p, and MIR92A-5p to be increased in tumor tissues, whereas levels of MIR143-3p, MIR204-5p, and MIR133-3p were decreased in tumor tissues. Levels of MIR143-3p were reduced not only in gastric cancer tissues but also in normal tissues adjacent to tumors in humans and low-grade dysplasia in mice. Transgenic expression of MIR143-3p in gastric cancer cell lines reduced their proliferation and restored their sensitivity to cisplatin. AGS cells with stable transgenic expression of MIR143-3p grew more slowly as xenograft tumors in mice than control AGS cells; tumor growth from AGS cells that expressed MIR143-3p, but not control cells, was sensitive to cisplatin. We identified and validated bromodomain containing 2 (BRD2) as a direct target of MIR143-3p; increased levels of BRD2 in gastric tumors was associated with shorter survival times for patients. CONCLUSIONS: In an analysis of miRNA profiles of gastric tumors from mice and human patients, we identified a conserved signature associated with the early stages of gastric tumorigenesis. Strategies to restore MIR143-3p or inhibit BRD2 might be developed for treatment of gastric cancer.
引用
- Chen Z, Li Z, Soutto M, et al. Integrated Analysis of Mouse and Human Gastric Neoplasms Identifies Conserved microRNA Networks in Gastric Carcinogenesis. Gastroenterology. 2018. PMID: 30502323. doi:10.1053/j.gastro.2018.11.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。